By vgreene, 13 April, 2021 FDA emergency use authorization for primary vaccine series to prevent COVID 19 in children and adolescents ages 6 mo to 18 yo and additional primary series dose in individuals 6 mo w certain types of immunocompromise
By vgreene, 13 April, 2021 COVID 19 Vaccines International Pregnancy Exposure Registry C VIPER website and clinical trials
